Testing blockchain technology for clinical trials in Canada

A recent article released by IBM Watson Health announced a collaboration between IBM Canada and Boehringer Ingelheim Canada Ltd. to test blockchain clinical trials. 

Advertisement

Editor’s Note: This article originally appeared on IBM’s website. 

The healthcare industry is undergoing significant changes due to the vast amounts of disparate data being generated. There is a huge need for transformative healthcare solutions where healthcare researchers, providers, and patients have access to a 360-degree view of health data. Blockchain technology provides a highly secure, decentralized framework for data sharing that could accelerate innovation throughout the industry.

Blockchain technology in healthcare has made significant strides in the last few years. IBM entered into research projects with the U.S. Food and Drug Administration and Center for Disease Control, and more recently announced a multi-company health utility network being formed to create an inclusive blockchain network that can benefit multiple members of the healthcare ecosystem in a secure, shared environment. Click here to continue>>

 

News From Our Partners 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.